期刊文献+

抗痛风药非布司他的晶型专利相关技术分析

Analysis of the Patent about the Crystal Form of Febuxostat
下载PDF
导出
摘要 非布司他是一种全新的非嘌呤类黄嘌呤氧化还原酶选择性抑制剂,临床用于治疗痛风,文章以中国范围内的专利申请数据为分析样本,对非布司他的晶型相关专利进行分析,总结该领域的专利申请现状和研究进展,为我国医药企业对于该药物的研究提供建议。 Febuxostat is new non-purines xanthine oxido-reductase selective inhibition. It uses for treating gout. The article analyzes the patent about the crystal form of Febuxostat, from the patent application in China, in order to learn the development in the field and patent application status, and make recommendations for pharmaceutical companies.
出处 《广东化工》 CAS 2017年第2期75-76,共2页 Guangdong Chemical Industry
关键词 非布司他 晶型 专利 febuxostat crystal form: patent
  • 相关文献

参考文献3

二级参考文献33

  • 1Yu KH. Febuxostat : a novel non-purlne selective inhibitor of xanthine oxidase for the treatment of hyperuricemia in gout[ J]. Recent Pat lnflamm Allergy Drug Discov,2007,1 ( 1 ) :69-75.
  • 2Mayer M, Khosravan DR. Pharmacokinetics and pharmacodynamics of febuxostat,a new non-purine selective inhibitor of xanthine oxidase in subjects with renal impairment [ J ]. Am J Ther,2005,12 ( 1 ) :22-34.
  • 3Lustberg, ME. Febuxostat versus allopurinol for gout [ J ]. N Engl J Med, 2006, 354(14) :1532-1533.
  • 4Schumacher H R, Becker MA. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout : a 28 -week, phase Ⅲ, randomized, double-blind, parallel-group trial [ J ]. Arthitis Rheum, 2008,59( 11 ) :1540-1548.
  • 5Khosravan R J, Wu T. Pharmacokinetic interactions of concomitant administration of febuxostat and NSAIDs[ J]. J Clin Pharmacol,2006,46(8) :855-866.
  • 6Schumacher HR, Becker MA. Febuxostat in the treatment of gout :5-y findings of the FOCUS efficacy and safety study [ J ]. Rheumatology ( Oxford), 2009,48 (2) : 188-194.
  • 7Bruce SP. Febuxostat:a selective xanthine oxidase inhibitor for the treatment of hyperuricemia and gout[ J]. Ann Pharmacothe,2006,40(12) :2187-2194.
  • 8Mukoyoshi M, Nishimura S. In vitro drug-drug interaction studies with febux- ostat, a novel non-purine selective inhibitor of xanthine oxidase : plasma protein binding,identification of metabolic enzymes and cytochome P450 inhibition[ J]. Xenobiotica ,2008,38 ( 5 ) :496-510.
  • 9Alfonso Gutiérrez-Maclas,EValizarralde-Palaeios,Pedro Martínez-Odriozola.Fatal allopurinol hypersensitivity syndrome after treatment of a-symptomatic hyperuricaemia[J].BMJ,2005,331:623-624.
  • 10Tausche AK,Aringer M,Schroeder HE.The Janus Faces of Allopurinol-Allopurinol hypersensitivity syndrome[J].Am J Med,2008,121:e3-e4.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部